. 2014 Nov;50(16):2763–2770. doi: 10.1016/j.ejca.2014.08.002

Table 6.

Factors influencing chemotherapy prescribing following the introduction of Oncotype DX testing.

Factor	Significance	OR
Interval^†	0.04
Oncotype not publicly reimbursed	0.15	0.32
Oncotype routinely used	0.017	0.41

Grade^‡	0.24
Grade 2	0.15	2.17
Grade 3	0.78	1.22

Size	0.59	1.01
Age	0.04	0.96
Oncotype score	<0.001	1.33

^†

Compared to period of trial recruitment.

^‡

Compared to grade I.